曹聪教授在美国常青藤盟校Brown University（布朗大学）进行7年博士和博士后学习，在认知功能障碍发生机制及靶向干预、神经损伤及修复、神经肿瘤新癌基因鉴定及干预等方面积累了丰富的研究经验，有扎实的理论基础和实验技能。自2012年8月回国至今，发表（共同）第一/通讯作者SCI论文24篇，累计影响因子132.1，其中通讯作者SCI论文21篇，SCI一区论文8篇。主持省级及以上课题8项；另外获得省级人才项目4项。代表性论文发表在PNAS*，Science Signaling，PLoS Biology，Oncogene*，FASEB J*，Theranostics*，Nano Letters和Journal of Investigative Dermatology*等杂志上（*为Lead Contact）。发表的论文受到国际权威杂志包括Science，Science Signaling，Faculty 1000，Science Daily焦点报道。2014年受邀知名SCI杂志PLoS ONE出任学术编辑，2014年当选江苏省药理协会青年协会副主任委员，2015-2016年入选教育部“长江学者”评审专家。2016-2020年为国自然基金委“面上项目”评审专家。
抑郁及相关脑疾病神经生物学机制研究
代表性论著：
(1) Marshall John; Zhou Xiao zhong; Chen Gang; Yang Su qing; Li Ya; Wang Yin; Zhang Zhi qing; Jiang Qin; Birnbaumer Lutz; Cao Cong. Antidepression action of BDNF requires and is mimicked by Galpha i1/3 expression in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America, 2018.04.10, 115(15): E3549~E3558.
(2) Liu Yuan yuan; Chen Min Bin; Cheng Long; Zhang Zhi qing; Yu Zheng quan; Jiang Qin*; Chen Gang; Cao Cong. microRNA-200a downregulation in human glioma leads to Galphai1 over-expression, Akt activation, and cell proliferation. Oncogene, 2018.05, 37(21): 2890~2902.
(3) Sun Jian; Huang Wei; Yang Shuo fei; Zhang Xiao pei; Yu Qing; Zhang Zhi qing; Yao Jin ; Li Ke ran; Jiang Qin; Cao Cong. Galphai1 and Galphai3 mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis. Theranostics, 2018, 8(17): 4695~4709.
(4) Cao, Cong; Rioult-Pedotti, Mengia S; Migani, Paolo; Yu, Crystal J; Tiwari, Rakesh; Parang, Keykavous; Spaller, Mark R; Goebel, Dennis J; Marshall, John. Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biology, 2013, 11(2): e1001478 .
(5) Cao Cong ; Huang Xuesong; Han Yuyuan; Wan Yinsheng; Birnbaumer Lutz; Feng Geng Sheng; Marshall John; Jiang Meisheng; Chu Wen Ming. Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Science Signaling, 2009.4.28, 2(68): ra17.曹聪教授在美国常青藤盟校Brown University（布朗大学）进行7年博士和博士后学习，在认知功能障碍发生机制及靶向干预、神经损伤及修复、神经肿瘤新癌基因鉴定及干预等方面积累了丰富的研究经验，有扎实的理论基础和实验技能。自2012年8月回国至今，发表（共同）第一/通讯作者SCI论文24篇，累计影响因子132.1，其中通讯作者SCI论文21篇，SCI一区论文8篇。主持省级及以上课题8项；另外获得省级人才项目4项。代表性论文发表在PNAS*，Science Signaling，PLoS Biology，Oncogene*，FASEB J*，Theranostics*，Nano Letters和Journal of Investigative Dermatology*等杂志上（*为Lead Contact）。发表的论文受到国际权威杂志包括Science，Science Signaling，Faculty 1000，Science Daily焦点报道。2014年受邀知名SCI杂志PLoS ONE出任学术编辑，2014年当选江苏省药理协会青年协会副主任委员，2015-2016年入选教育部“长江学者”评审专家。2016-2020年为国自然基金委“面上项目”评审专家。
抑郁及相关脑疾病神经生物学机制研究
代表性论著：
(1) Marshall John; Zhou Xiao zhong; Chen Gang; Yang Su qing; Li Ya; Wang Yin; Zhang Zhi qing; Jiang Qin; Birnbaumer Lutz; Cao Cong. Antidepression action of BDNF requires and is mimicked by Galpha i1/3 expression in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America, 2018.04.10, 115(15): E3549~E3558.
(2) Liu Yuan yuan; Chen Min Bin; Cheng Long; Zhang Zhi qing; Yu Zheng quan; Jiang Qin*; Chen Gang; Cao Cong. microRNA-200a downregulation in human glioma leads to Galphai1 over-expression, Akt activation, and cell proliferation. Oncogene, 2018.05, 37(21): 2890~2902.
(3) Sun Jian; Huang Wei; Yang Shuo fei; Zhang Xiao pei; Yu Qing; Zhang Zhi qing; Yao Jin ; Li Ke ran; Jiang Qin; Cao Cong. Galphai1 and Galphai3 mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis. Theranostics, 2018, 8(17): 4695~4709.
(4) Cao, Cong; Rioult-Pedotti, Mengia S; Migani, Paolo; Yu, Crystal J; Tiwari, Rakesh; Parang, Keykavous; Spaller, Mark R; Goebel, Dennis J; Marshall, John. Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biology, 2013, 11(2): e1001478 .
(5) Cao Cong ; Huang Xuesong; Han Yuyuan; Wan Yinsheng; Birnbaumer Lutz; Feng Geng Sheng; Marshall John; Jiang Meisheng; Chu Wen Ming. Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Science Signaling, 2009.4.28, 2(68): ra17.